Drug-related adverse events
| Orvepitant 30 mg n=16 n (%) | Orvepitant 10 mg n=14 n (%) | Placebo n=14 n (%) | |
| Any drug-related AE | 3 (18.8) | 1 (7.1) | 0 |
| Mild AEs | |||
| Asthenia | 1 (6.3) | 0 | 0 |
| Dizziness | 0 | 1 (7.1) | 0 |
| Dry mouth | 1 (6.3) | 0 | 0 |
| Moderate AEs | |||
| Hyperhidrosis | 1 (6.3) | 0 | 0 |
AE, adverse event.